Genetic diversity and high proportion of intersubtype recombinants among HIV type 1-infected pregnant women in Kisumu, western Kenya

AIDS Research and Human Retroviruses

Volumn 20, Issue 5, 2004, Pages 565-574

  Yang, Chunfu ^a,e   Li, Ming ^a   Shi, Ya Ping ^b,c   Winter, Jorn ^a   Van Eijk, Anna M ^c   Ayisi, John ^c   Hu, Dale J ^a   Steketee, Richard ^b   Nahlen, Bernard L ^d   Lal, Renu B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e Immunology Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GAG PROTEIN; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL;

EID: 2642538419     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922204323087822     Document Type: Article

References (44)

1. McCutchan FE: Understanding the genetic diversity of HIV-1. AIDS 2000;14(Suppl. 3):S31-S44.
2. Peeters M and Sharp PM: The genetic diversity of HIV-1: The moving target. AIDS 2000;14(Suppl. 3):S129-S140.
3. Hu DJ, Buve A, Baggs J, van der Groen G, and Dondero TJ: What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999;13:873-881.
4. Robertson DL, Sharp PM, McCutchan FE, and Hahn BH: Recombination in HIV-1. Nature 1995;374:124-126.
5. Quinones-Mateu ME and Arts EJ: Recombination in HIV-1: Update and implications. AIDS Rev 1999;1:89-100.
6. Kuiken C, Foley B, Freed E, Hahn B, et al. (eds.): HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2002.
7. Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, and Dougherty JP: High rate of recombination throughout the human immunodeficiency virus type 1 genome. J Virol 2000;74:1234-1240.
8. Blackard JT, Cohen DE, and Mayer KH: Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences. Clin Infect Dis 2002;34:1108-1114.
9. UNAIDS/WHO: Epidemiological fact sheet on HIV/AIDS and sexually transmitted infections: Kenya, 2001 Update. In: Joint United Nations Programme on HIV/AIDS/World Organization. UN-AIDS/WHO, Geneva, Switzerland, 2001.
10. Janssens W, Heyndrickx L, Fransen K, et al.: Genetic variability of HIV type 1 in Kenya. AIDS Res Hum Retroviruses 1994;10:1577-1579.
11. Poss M, Gosink J, Thomas E, et al.: Phylogenetic evaluation of Kenyan HIV type 1 isolates. AIDS Res Hum Retroviruses 1997;13:493-499.
12. Zachar V, Goustin AS, Zacharova V, et al.: Genetic polymorphism of envelope V3 region of HIV type 1 subtypes A. C. and D from Nairobi, Kenya. AIDS Res Hum Retroviruses 1996;12:75-78.
13. Neilson JR, John GC, Carr JK, et al.: Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999;73:4393-4403.
14. Heyndrickx L, Janssens W, Zekeng L, et al.: Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J Virol 2000;74:363-370.
15. Morison L, Buve A, Zekeng L, et al.: HIV-1 subtypes and the HIV epidemics in four cities in sub-Saharan Africa. AIDS 2001;15 (Suppl. 4):S109-S116.
16. Burns CC, Gleason LM, Mozaffarian A, Giachetti C, Carr JK, and Overbaugh J: Sequence variability of the integrase protein from a diverse collection of HTV type 1 isolates representing several subtypes. AIDS Res Hum Retroviruses 2002;18:1031-1041.
17. Gao F, Vidal N, Li Y, et al.: Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation. AIDS Res Hum Retroviruses 2001:17:675-688.
18. Dowling WE, Kim B, Mason CJ, et al.: Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002;16:1809-1820.
19. Songok EM, Lihana RW, Kiptoo EM, et al.: Identification of env CRF-10 among HIV variants circulating in rural western Kenya. AIDS Res Hum Retroviruses 2003;19:161-165.
20. Yang C, Li M, Newman RD, et al.: Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 2003;17:1667-74.
21. Wright NH, Vanichseni S, Akarasewi P, Wasi C, and Choopanya K: HIV epidemic among Bangkok's injecting drugs users a common source outbreak? AIDS 1994;8:529-532.
22. Subbarao S, Limpakarnjanarat K, Mastro TD, et al.: HIV-1 in Thailand, 1994-1995: Persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998;14:319-327.
23. Amornkul PN, Tansuphasawadikul S, Limpakarnjanarat K, et al.: Clinical disease associated with HIV-1 subtype B′ and E infection among 2104 patients in Thailand. AIDS 1999;13:1963-1969.
24. Francis DP, Gregory T, McElrath MJ, et al.: Advancing AIDSVAX to phase 3. Safety, immunogenjcity, and plans for phase 3. AIDS Res Hum Retroviruses 1998;14(Suppl. 3):S325-S331.
25. Hanke T and McMichael AJ: Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trials in Kenya. Nat Med 2000;6:951-955.
26. Ayisi JG, van Eijk AM, Newman RD, et al.: Maternal malaria and perinatal HIV transmission in western Kenya. J Emerg Infect 2004;10:643-652.
27. Yang C, Dash BC, Simon F, et al.: Detection of diverse variants of HIV-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees using generic pol and env primer pairs. J Infect Dis 2000;181:1791-1795.
28. Yang C, Dash B, Hanna SL, et al.: Predominance of subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses 2001;17:361-365.
29. Thompson JD, Higgins DG, Gibson TJ: CLUSTALW: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
30. Carr JK, Foley BT, Leitner T, Salminen M, Korber B, and McCutchan F: Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human Retrovirus and AIDS (Korber B, Kuiken C, Foley B, et al., eds.) Los Alamos National Laboratory, Los Alamos, NM, 1998, pp. III10-III19.
31. Hall T: BioEdit: A user-friendly biological sequence alignment editor and analysis program for window96/98/NT. Nucleic Acids Symp Ser No 41, 1999;95-98.
32. Felsenstein, J: PHYLIP-phylogeny interference package (version 3.2). Cladistics 1989;5:164-166.
33. Hills DM and Bull JJ: An empirical test of bootstrapping as a method for assessing confidence in phylogenetic trees. Syst Biol 1993;42:182-192.
34. Salminen MO, Carr JK, Burke DS, and McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995;11:1423-1425.
35. Koulinska IN, Msamanga G, Mwakagile D, Essex M, and Renjifo B: Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania. AIDS Res Hum Retroviruses 2002;18:947-956.
36. Ferrari G, Kostyu DD, Cox J, et al.: Identification of highly conserved and broadly cross-reactive HIV-type 1 cytotoxic T lymphocytes epitopes as candidate immunogens for inclusion in Mycobacterium bovis BDG-vectored HIV vaccines. AIDS Res Human Retrovirus 2000;16:1433-1443.
37. Goulder PJ, Brander C, Tang Y, et al.: Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001;412:334-338.
38. Sarkar S, Kalia V, Murphey-Corb M, and Montelaro RC: Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope. J Immunol 2002;168:4001-4011.
39. Bird TG, Kaul R, Rostron T, et al.: HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS 2002;16:1899-1904.
40. Surman S, Lockey TD, Slobod KS, et al.: Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing. Proc Natl Acad Sci USA 2001;98:4587-4592.
41. Betts MR, Krowka J, Santamaria C, et al.: Cross-clade human immunodeficiency virus (HTV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol 1997;71:8908-8911.
42. Cao H, Kanki P, Sankale JL, et al.: Cytotoxic T-lymphocyte crossreactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development J Virol 1997;71:8615-8623.
43. Cao H, Mani I, Vincent R, et al.: Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda. J Infect Dis 2000;182:1350-1356.
44. Dorrell L, Dong T, Ogg GS, et al.: Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa. J Virol 1999;73:1708-1714.